Clinical Trial Update: Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety of CDNF via brain infusion in Parkinson's disease, extending the HP-CD-CL-2002 study; completed Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CDNF (Cerebral Dopamine Neurotrophic Factor)

Snippet

Sponsor: Herantis Pharma Plc. | Conditions: Parkinson Disease, Movement Disorders | Phase 1, Phase 2 | Status: COMPLETED